Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hirokazu Kanegane |
| Publication date | June 1, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |